Reply to comments on: "Efficacy of cx601 (darvadstrocel) for the treatment of perianal fistulizing Crohn's disease-A  prospective nationwide multicenter cohort study"

Wien Klin Wochenschr. 2024 Apr 23. doi: 10.1007/s00508-024-02363-z. Online ahead of print.NO ABSTRACTPMID:38652312 | DOI:10.1007/s00508-024-02363-z

Source: Wiener Klinische Wochenschrift - April 23, 2024 Category: General Medicine Authors: Stefan Riss Christopher Dawoud Source Type: research